THE ASTRAZENECA vaccine hesitancy that has swept across Europe has been rebuffed by a new US study. The study found the jab 100 percent effective at preventing severe illness and hospitalisation. Crucially, no blood clot issues were reported either.
Daily Express :: Health Feed
